Company facts
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 10-Q, filed Jul 31, 2026
- Incorporated
- Delaware
- Filings on record
- 1,002+ filings
- On EDGAR
- CIK 1682852
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 22
News 8 of 60
Prospectuses and Registrations 4
Proxies 8 of 18
- DEFA14A Extra proxy material Mar 16, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 16, 2026
- DEFA14A Extra proxy material Oct 20, 2025
- DEF 14A Proxy statement for a shareholder vote Oct 15, 2025
- PRE 14A Preliminary proxy statement Oct 3, 2025
- DEFA14A Extra proxy material Mar 11, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 11, 2025
- DEFA14A Extra proxy material Mar 21, 2024
Ownership 8 of 881
- SCHEDULE 13G Large holder reported a passive stake Aug 12, 2026
- 4 Insider reported a trade Aug 7, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 6, 2026
- 144 Notice of a proposed sale of restricted stock Aug 5, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 24, 2026
- 4 Insider reported a trade Jul 16, 2026
- 144 Notice of a proposed sale of restricted stock Jul 15, 2026
- 4 Insider reported a trade Jul 10, 2026
Other 8 of 17
Everything here comes from Moderna, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.